Businesses

Four platforms, one continuum.

From synthetic intermediates to finished medicines and biologics, our businesses share chemistry, manufacturing and quality muscle — and reinforce each other across the value chain.

II·01

Active Pharmaceutical Ingredients

Complex generic and innovator APIs for regulated markets — ARV, oncology, cardiovascular, CNS and metabolic therapies.

01Multi-step synthesis & complex intermediates
02Chiral chemistry · asymmetric routes
03Process intensification & flow chemistry
04Regulatory dossiers — DMF, CEP, ASMF

II·02

Finished Dosage Forms

Solid orals, semi-solids and sterile dosages — formulation development to commercial-scale supply.

01Immediate & modified release tablets
02Sterile injectables & lyophilisation
03Inhalation & semi-solid platforms
04Bioequivalence & clinical strategy

II·03

Biotechnology

Recombinant proteins, peptides and biosimilars — end-to-end from cell-line to fill-finish.

01Cell-line & strain development
02Upstream & downstream process design
03Analytical characterisation
04Fill-finish & packaging

II·04

CDMO & Custom Synthesis

Integrated contract development & manufacturing for innovators — chemistry to commercial supply.

01Route scouting · process development
02Tech-transfer & scale-up
03GMP manufacturing campaigns
04Regulatory & quality support